News & Events

Read up on the latest about Braveheart.

Corporate Overview

Events & Presentations

News

Braveheart Bio to Present at 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026

Braveheart secures $185M to advance challenger to Bristol Myers heart drug

November 5, 2025

Cardio biotech Braveheart gets $185M, names Biogen CEO as its chair

November 5, 2025

Braveheart Bio launches with mission to conquer heart disease market, capturing $185M series A

November 5, 2025

Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy

November 5, 2025

Travis Murdoch speaks with Endpoints News on Braveheart Bio’s licensing announcement

September 4, 2025

Braveheart Bio posts promising China data in heart disease where Bristol Myers, Cytokinetics have drugs

March 30, 2026 10:24 AM

Braveheart Bio Presents at 44th Annual J.P. Morgan Healthcare Conference

January 16, 2026 8:00 AM

Braveheart Bio launches with mission to conquer heart disease market, capturing $185M series A

November 5, 2025 8:39 AM

Cardio biotech Braveheart gets $185M, names Biogen CEO as its chair

November 5, 2025 4:37 PM

Braveheart secures $185M to advance challenger to Bristol Myers heart drug

November 5, 2025 7:34 PM

Travis Murdoch speaks with Endpoints News on Braveheart Bio’s licensing announcement

September 4, 2025 6:30 PM

Hengrui Pharma and Braveheart Bio Announce Positive Phase 2 Results with HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy

March 30, 2026 8:30 AM

Braveheart Bio Appoints Emil deGoma, M.D., as Chief Medical Officer

March 26, 2026 8:00 AM

Braveheart Bio to Participate in TD Cowen 46th Annual Health Care Conference

February 23, 2026 8:05 AM

Braveheart Bio Announces Senior Leadership Appointments to Strengthen Scientific and Operational Capabilities While Advancing Global Phase 3 Development

February 5, 2026 8:05 AM

Braveheart Bio to Present at 44th Annual J.P. Morgan Healthcare Conference

January 6, 2026 8:00 AM

Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy

November 5, 2025 6:00 AM

Download our Corporate Overview

Events and Presentations

Apr 1, 2026

Piper Sandler Virtual Cardio Symposium with ACC 2026 Conference Takeaways

Virtual Fireside Chat

Mar 28, 2026

New Orleans, LA

American College of Cardiology 75th Annual Scientific Session

Presentation: Efficacy and Safety of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From a 12-Week Phase 2 Study

Download Presentation

Mar 2, 2026

Boston, MA

46th Annual TD Cowen Healthcare Conference

Feb 24, 2026

Cantor Rare Disease Month Webinar

Virtual Fireside Chat

Jan 16, 2026

San Francisco, CA

44th Annual J.P. Morgan Healthcare Conference

Download Presentation

Aug 29, 2025

Madrid, Spain

European Society of Cardiology Congress 2025

Presentation: HRS-1893, a cardiac myosin inhibitor, in patients with obstructive hypertrophic cardiomyopathy

Download Presentation

No upcoming events as of today.

Apr 1, 2026

Piper Sandler Virtual Cardio Symposium with ACC 2026 Conference Takeaways

Virtual Fireside Chat

Mar 28, 2026

New Orleans, LA

American College of Cardiology 75th Annual Scientific Session

Presentation: Efficacy and Safety of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From a 12-Week Phase 2 Study

Download Presentation

Mar 2, 2026

Boston, MA

46th Annual TD Cowen Healthcare Conference

Feb 24, 2026

Cantor Rare Disease Month Webinar

Virtual Fireside Chat

Jan 16, 2026

San Francisco, CA

44th Annual J.P. Morgan Healthcare Conference

Download Presentation

Aug 29, 2025

Madrid, Spain

European Society of Cardiology Congress 2025

Presentation: HRS-1893, a cardiac myosin inhibitor, in patients with obstructive hypertrophic cardiomyopathy

Download Presentation

[data-wf-bgvideo-fallback-img] { display: none; } @media (prefers-reduced-motion: reduce) { [data-wf-bgvideo-fallback-img] { position: absolute; z-index: -100; display: inline-block; height: 100%; width: 100%; object-fit: cover; } }

Interested in joining our team?

Learn more about our openings.